Correlation Between Pyrum Innovations and PCI Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pyrum Innovations and PCI Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyrum Innovations and PCI Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyrum Innovations AG and PCI Biotech Holding, you can compare the effects of market volatilities on Pyrum Innovations and PCI Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyrum Innovations with a short position of PCI Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyrum Innovations and PCI Biotech.

Diversification Opportunities for Pyrum Innovations and PCI Biotech

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Pyrum and PCI is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Pyrum Innovations AG and PCI Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCI Biotech Holding and Pyrum Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyrum Innovations AG are associated (or correlated) with PCI Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCI Biotech Holding has no effect on the direction of Pyrum Innovations i.e., Pyrum Innovations and PCI Biotech go up and down completely randomly.

Pair Corralation between Pyrum Innovations and PCI Biotech

Assuming the 90 days trading horizon Pyrum Innovations AG is expected to generate 0.35 times more return on investment than PCI Biotech. However, Pyrum Innovations AG is 2.83 times less risky than PCI Biotech. It trades about 0.25 of its potential returns per unit of risk. PCI Biotech Holding is currently generating about -0.02 per unit of risk. If you would invest  32,300  in Pyrum Innovations AG on October 22, 2024 and sell it today you would earn a total of  2,200  from holding Pyrum Innovations AG or generate 6.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pyrum Innovations AG  vs.  PCI Biotech Holding

 Performance 
       Timeline  
Pyrum Innovations 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pyrum Innovations AG are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Pyrum Innovations may actually be approaching a critical reversion point that can send shares even higher in February 2025.
PCI Biotech Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PCI Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pyrum Innovations and PCI Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pyrum Innovations and PCI Biotech

The main advantage of trading using opposite Pyrum Innovations and PCI Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyrum Innovations position performs unexpectedly, PCI Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PCI Biotech will offset losses from the drop in PCI Biotech's long position.
The idea behind Pyrum Innovations AG and PCI Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine